Conjoint Professor David Henry

Conjoint Professor

School of Medicine and Public Health

Career Summary

Biography

Research Expertise
Evidence based medicine, adverse drug reactions pharmacovigilance, pharmaco-epidemiology and pharmaco-economics

Teaching Expertise
Clinical medicine, clinical pharmacology, rational drug use, pharmaco-epidemiology and pharmaco-economics

Administrative Expertise
I have been discipline head since 1997 and have also served as Head of School (Population Health Sciences) and deputy head of school (Medicine and Population Health) at different times. I am Director of the Newcastle Institute of Public Health and Director of the WHO Collaborating Centre for Training in Pharmaco-economics and Rational Pharmacotherapy at the University of Newcastle. I am chair of medical staff council of the Newcastle Mater Hospital and have served on multiple committees, including ethics committees of the University and health service. I have been a member of several national committees concerned with drug regulation and for 8 years chaired the economics subcommittee of the Commonwealth governments Pharmaceutical Benefits Advisory Committee

Qualifications

  • Bachelor of Medicine, Bachelor of Surgery, University of Glasgow - Scotland

Keywords

  • Clinical Pharmacology
  • General Medicine
  • Pharmaco-economics
  • Pharmaco-epidemiology

Fields of Research

Code Description Percentage
160508 Health Policy 25
110399 Clinical Sciences not elsewhere classified 35
111799 Public Health and Health Services not elsewhere classified 40

Professional Experience

Academic appointment

Dates Title Organisation / Department
Director - World Health Organisation Collaborating Centre for Training in Pharmo-economics and Rational Pharmacotherapy World Health Organisation Collaborating Centre
Australia
1/01/2007 -  Chair Medical Staff Council, Newcastle Mater Hospital
Australia
1/02/1983 - 1/08/1996 Senior Lecturer in Clinical Pharmacology University of Newcastle
School of Medicine and Public Health
Australia
1/01/1978 - 1/02/1983 Lecturer in Therapeutics The University of Nottingham
Department of Therapeutics
United Kingdom

Membership

Dates Title Organisation / Department
Member, Panel of Referees for Project Grants - Canadian Institutes of Health Research Canadian Institutes of Health Research (CIHR)
Canada
Member - South African National Medicines Pricing Committee South African National Medicines Pricing Committee
South Africa
Member, Panel of Referees for Project Grants - National Health and Medical Research Council National Health and Medical Research Council
Australia
Member, Panel of Referees for Project Grants - Medical Research Council of New Zealand Medical Research Council of New Zealand
New Zealand
Member, Panel of Referees for Project Grants - Medical Research Council (UK) Medical Research Council of the United Kingdom
United Kingdom
Member - International Society of Pharmacoepidemiology International Society of Pharmacoepidemiology
Australia
Member - Australasian Society of Clinical and Experimental Pharamcologists Australasian Society of Clinical and Experimental Pharamcologists
Australia

Awards

Recipient

Year Award
2005 Eureka Skeptics Prize for Critical Thinking
Australian Museum
2001 Thomas Chalmers Memorial Award
Unknown

Invitations

Participant

Year Title / Rationale
2007 Pharmaco-economics
Organisation: World Health Organisation
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (6 outputs)

Year Citation Altmetrics Link
2005 Henry DA, McGettigan PG, Anne T, Sean H, 'Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies', Pharmacoepidemiology, John Wiley & Sons, Hoboken 867 (2005) [B1]
Co-authors Mddah01
2001 O'Connell DL, Glasziou P, Hill SR, Sarunac J, Lowe J, Henry DA, 'Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply?', The Advanced Handbook of Methods in Evidence Based Healthcare, Sage Publications Ltd, London England 56-72 (2001) [B1]
Co-authors Mddah01
2001 Hill SR, Henry DA, Stevens A, 'The use of evidence in drug selection: The Australian Pharmaceutical Benefits Scheme', Informing Judgment: Case Studies of Health Policy and Research in Six Countries, Milbank Memorial Fund, U.S.A. 7-27 (2001) [B2]
Co-authors Mddah01
2000 McGettigan PG, Henry DA, Hennessy S, 'Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies', Pharmacoepidemiology, John Wiley & Sons, West Sussex. England 41-62 (2000) [B1]
Co-authors Mddah01
2000 Hill SR, Henry DA, 'National Medicinal Drug Policies: their Relationship to Pharmacoepidemiology', Pharmacoepidemiology, John Wiley & Sons Ltd, Great Britain 433-447 (2000) [B1]
Co-authors Mddah01
1999 Henry DA, Drew A, Beuzeville S, 'Gastrointestinal Adverse Drug Reactions Attributed to Ibuprofen', Ibuprofen A critical bibliographic review, T.J. International Ltd., Cornwall UK 431-458 (1999) [B1]
Co-authors Mddah01
Show 3 more chapters

Journal article (116 outputs)

Year Citation Altmetrics Link
2014 Robertson J, Doran E, Henry DA, Salkeld G, 'Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy', Health Expectations, 17 15-26 (2014) [C1]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly fun... [more]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly funded health care system. Design and setting Cross-sectional telephone survey of randomly selected regular medicine users aged =18years in the Hunter Valley, NSW, Australia. Main variables studied Questions about 27 medicine attributes and active involvement in decisions to start a new medicine. Results After adjustment, there were few differences between the 408 concession card holders (high insurance) and 410 general beneficiaries (low insurance) in their assessment of the importance of medicine attributes. For both groups, the explanation of treatment options, establishing the need for the medicine, and medicine efficacy and safety were the most important considerations. Medicine costs, the treatment burden and medicine familiarity were less important; the views of family and friends ranked lowest. There was a statistically significantly greater influence of the regular doctor for the concession card holders than general beneficiaries (93.6 vs. 84%, adjusted OR 2.80, 95% CI 1.31, 5.99). Concession card holders were more likely to favour doctors having more say in the decision-making process (crude OR 1.69, 95% CI 1.28, 2.24), and more likely to report the most recent treatment decision being made by the doctor alone, compared with general beneficiaries (61.2 vs. 40.3%). Conclusion Medicine need, efficacy and safety are viewed as paramount for most patients, irrespective of insurance status. While patients report the importance of participation in treatment decisions, delegation of decision making to the doctor was common in practice. © 2011 John Wiley & Sons Ltd.

DOI 10.1111/j.1369-7625.2011.00715.x
Citations Scopus - 1Web of Science - 1
Co-authors Mddah01
2014 Robertson J, Doran E, Henry DA, Salkeld G, 'Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy', Health Expectations, 17 15-26 (2014) [C1]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly fun... [more]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly funded health care system. Design and setting Cross-sectional telephone survey of randomly selected regular medicine users aged =18years in the Hunter Valley, NSW, Australia. Main variables studied Questions about 27 medicine attributes and active involvement in decisions to start a new medicine. Results After adjustment, there were few differences between the 408 concession card holders (high insurance) and 410 general beneficiaries (low insurance) in their assessment of the importance of medicine attributes. For both groups, the explanation of treatment options, establishing the need for the medicine, and medicine efficacy and safety were the most important considerations. Medicine costs, the treatment burden and medicine familiarity were less important; the views of family and friends ranked lowest. There was a statistically significantly greater influence of the regular doctor for the concession card holders than general beneficiaries (93.6 vs. 84%, adjusted OR 2.80, 95% CI 1.31, 5.99). Concession card holders were more likely to favour doctors having more say in the decision-making process (crude OR 1.69, 95% CI 1.28, 2.24), and more likely to report the most recent treatment decision being made by the doctor alone, compared with general beneficiaries (61.2 vs. 40.3%). Conclusion Medicine need, efficacy and safety are viewed as paramount for most patients, irrespective of insurance status. While patients report the importance of participation in treatment decisions, delegation of decision making to the doctor was common in practice. © 2011 John Wiley & Sons Ltd.

DOI 10.1111/j.1369-7625.2011.00715.x
Citations Scopus - 1
Co-authors Mddah01
2014 Gershon AS, Khan S, Klein-Geltink J, Wilton D, To T, Crighton EJ, et al., 'Asthma and Chronic Obstructive Pulmonary Disease (COPD) Prevalence and Health Services Use in Ontario Metis: A Population-Based Cohort Study', PLOS ONE, 9 (2014) [C1]
DOI 10.1371/journal.pone.0095899
Citations Scopus - 4Web of Science - 2
Co-authors Mddah01
2013 Stukel TA, Glazier RH, Schultz SE, Guan J, Zagorski BM, Gozdyra P, Henry DA, 'Multispecialty physician networks in Ontario', Open Medicine, 7 1-16 (2013) [C1]
Citations Scopus - 1
Co-authors Mddah01
2013 Searles A, Doran E, Faunce TA, Henry D, 'The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?', AUSTRALIAN HEALTH REVIEW, 37 32-40 (2013) [C1]
DOI 10.1071/AH11153
Citations Scopus - 1Web of Science - 1
Co-authors Mddah01
2013 Robertson J, McElduff P, Pearson S-A, Henry DA, Inder KJ, Attia JR, 'The health services burden of heart failure: an analysis using linked population health data-sets (vol 12, pg 103, 2012)', BMC HEALTH SERVICES RESEARCH, 13 (2013) [O1]
DOI 10.1186/1472-6963-13-179
Co-authors John Attia, Mddah01, Patrick Mcelduff, Kerry Inder
2011 McGettigan P, Henry DA, 'Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies', PloS Medicine, 8 e1001098 (2011) [C1]
Citations Scopus - 163Web of Science - 106
Co-authors Mddah01
2011 McGettigan P, Lincz L, Attia JR, McElduff P, Bissett L, Peel R, et al., 'The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene', British Journal of Clinical Pharmacology, 72 707-714 (2011) [C1]
DOI 10.1111/j.1365-2125.2011.03957.x
Citations Scopus - 6Web of Science - 6
Co-authors Mddah01, Lisa Lincz, John Attia, Patrick Mcelduff, Barrie Stokes, Roseanne Peel
2010 Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, et al., 'Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department', Circulation, 122 1806-1814 (2010) [C1]
DOI 10.1161/CIRCULATIONAHA.110.940262
Citations Scopus - 41Web of Science - 40
Co-authors Mddah01
2010 Wilson AJ, Robertson J, McElduff P, Jones AL, Henry DA, 'Does it matter who writes medical news stories?', PLoS Medicine, 7 1-5 (2010) [C1]
DOI 10.1371/journal.pmed.1000323
Citations Scopus - 9Web of Science - 4
Co-authors Patrick Mcelduff, Amanda Wilson, Mddah01
2010 Henry DA, 'Doctors and drug companies: Still cozy after all these years', PLoS Medicine, 7 1-2 (2010) [C3]
Citations Scopus - 2
Co-authors Mddah01
2010 Wilson AJ, Bonevski B, Jones AL, Henry DA, 'Deconstructing cancer: What makes a good-quality news story?', Medical Journal of Australia, 193 702-706 (2010) [C1]
Citations Scopus - 1Web of Science - 1
Co-authors Mddah01, Billie Bonevski, Amanda Wilson
2010 McEvoy MA, Smith WT, D'Este CA, Duke JM, Peel R, Schofield PW, et al., 'Cohort Profile: The Hunter Community Study', International Journal of Epidemiology, 39 1452-1463 (2010) [C1]
DOI 10.1093/ije/dyp343
Citations Scopus - 54Web of Science - 53
Co-authors Julie Byles, Catherine Deste, John Attia, Rodney Scott, Derek Smith, Ben Ewald, Wayne Smith, Peter Schofield, Roseanne Peel, Mddah01
2010 Robertson J, Walkom EJ, Moynihan R, Bero L, Henry DA, 'Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme', International Journal of Pharmacy Practice, 18 88-92 (2010) [C1]
DOI 10.1211/ijpp/18.02.0003
Co-authors Mddah01, Emily Walkom
2010 Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'IQWiG methods - A response to two critiques', Health Economics, 19 1137-1138 (2010) [C3]
Citations Scopus - 4Web of Science - 1
Co-authors Mddah01
2010 Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'The efficiency frontier approach to economic evaluation of health-care interventions', Health Economics, 19 1117-1127 (2010) [C1]
DOI 10.1002/hec.1629
Citations Scopus - 38Web of Science - 27
Co-authors Mddah01
2010 Macneill PU, Kerridge IH, Newby DA, Stokes BJ, Doran E, Henry DA, 'Attitudes of physicians and public to pharmaceutical industry 'gifts'', Internal Medicine Journal, 40 335-341 (2010) [C1]
DOI 10.1111/j.1445-5994.2010.02233.x
Citations Scopus - 9Web of Science - 6
Co-authors Barrie Stokes, David Newby, Mddah01
2010 Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA, 'Cell salvage for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 1-181 (2010) [C1]
DOI 10.1002/14651858.CD001888.pub3
Citations Scopus - 46Web of Science - 15
Co-authors Mddah01
2010 Carless PA, Henry DA, Carson JL, Hebert PPC, McClelland B, Ker K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews, CD002042 (2010) [C1]
DOI 10.1002/14651858.CD002042.pub2
Citations Scopus - 30Web of Science - 24
Co-authors Mddah01
2009 Robertson J, Moynihan R, Walkom EJ, Bero L, Henry DA, 'Mandatory disclosure of pharmaceutical industry-funded events for health professionals', PLoS Medicine, 6 e1000128 (2009) [C1]
DOI 10.1371/journal.pmed.1000128
Citations Scopus - 7Web of Science - 2
Co-authors Emily Walkom, Mddah01
2009 Henry DA, Carless PA, Fergusson D, Laupacis A, 'The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis', Canadian Medical Association Journal, 180 183-193 (2009) [C1]
DOI 10.1503/cmaj.081109
Citations Scopus - 98Web of Science - 74
Co-authors Mddah01
2008 Doran E, Henry DA, 'Disease mongering: Expanding the boundaries of treatable disease', Internal Medicine Journal, 38 858-861 (2008) [C1]
DOI 10.1111/j.1445-5994.2008.01814.x
Citations Scopus - 11Web of Science - 10
Co-authors Mddah01
2008 Moynihan R, Doran E, Henry DA, 'Disease mongering is now part of the global health debate', PLoS Medicine, 5 0684-686 (2008) [C2]
DOI 10.1371/journal.pmed.0050106
Citations Scopus - 22Web of Science - 12
Co-authors Mddah01
2008 Wodak AD, Ali R, Henry DA, Sansom L, 'Ensuring the safety of new medications and devices: Are naltrexone implants safe?', Medical Journal of Australia, 188 438-439 (2008) [C3]
Co-authors Mddah01
2008 Doran E, Henry DA, Faunce TA, Searles AM, 'Australian pharmaceutical policy and the idea of innovation', Journal of Australian Political Economy, 62 39-61 (2008) [C1]
Citations Scopus - 2Web of Science - 1
Co-authors Mddah01
2008 Doran E, Henry DA, 'Australian pharmaceutical policy: Price control, equity, and drug innovation in Australia', Journal of Public Health Policy, 29 106-120 (2008) [C1]
DOI 10.1057/palgrave.jphp.3200170
Citations Scopus - 12Web of Science - 9
Co-authors Mddah01
2008 McGettigan PG, Han PY, Jones LJ, Whitaker DE, Henry DA, 'Selective COX-2 inhibitors, NSAIDs and congestive heart failure: Differences between new and recurrent cases', British Journal of Clinical Pharmacology, 65 927-934 (2008) [C1]
DOI 10.1111/j.1365-2125.2008.03121.x
Citations Scopus - 16Web of Science - 14
Co-authors Mddah01
2007 Pearson SA, Ringland C, Kelman C, Mant A, Lowinger J, Stark H, et al., 'Patterns of analgesic and anti-inflammatory medicine use by Australian veterans', Internal Medicine Journal, 37 798-805 (2007) [C1]
DOI 10.1111/j.1445-5994.2007.01516.x
Citations Scopus - 8Web of Science - 7
Co-authors Mddah01
2007 Henry DA, Carless PA, Moxey AJ, O'Connell DL, Stokes BJ, McClelland B, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', The Cochrane Database of Systematic Reviews, CD001886 (2007) [C1]
DOI 10.1002/14651858.cd001886.pub2
Citations Scopus - 22Web of Science - 86
Co-authors Mddah01, Barrie Stokes
2007 Salkeld G, Henry DA, Hill SR, Lang DL, Freemantle N, D'Assuncao J, 'What drives health-care spending priorities? An international survey of health-care professionals', Plos Medicine, 4 256-259 (2007) [C1]
DOI 10.1371/journal.pmed.0040094
Co-authors Danielle Lang, Mddah01
2007 Henry DA, McGettigan PG, 'Selective COX-2 inhibitors: A promise unfulfilled?', Gastroenterology, 132 790-794 (2007) [C3]
Co-authors Mddah01
2007 Kelman CW, Pearson SA, Day RO, D'Arcy C, Holman J, Kliewer EV, Henry DA, 'Evaluating medicines: let's use all the evidence', Medical Journal of Australia, 186 249-252 (2007) [C1]
Citations Scopus - 22Web of Science - 19
Co-authors Mddah01
2007 Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA, 'A Quality Use of Medicines program for general practitioners and older people: A cluster randomised controlled trial', Medical Journal of Australia, 187 23-30 (2007) [C1]
Citations Scopus - 53Web of Science - 46
Co-authors Mddah01, Julie Byles
2007 Searles AM, Jefferys S, Doran E, Henry DA, 'Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme', Medical Journal of Australia, 187 236-239 (2007) [C1]
Citations Scopus - 14Web of Science - 14
Co-authors Mddah01
2007 Henry DA, McGettigan PG, 'Cyclooxygenase inhibitors and cardiovascular risk - Reply', JAMA - Journal of the American Medical Association, 297 587-588 (2007) [C3]
Co-authors Mddah01
2006 McGettigan PG, Henry DA, 'Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase', JAMA - Journal of the American Medical Association, 296 1633-1644 (2006) [C1]
DOI 10.1001/jama.296.13.jrv60011
Co-authors Mddah01
2006 Doran E, Kerridge I, McNeill P, Henry DA, 'Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia', Social Science & Medicine, 62 1510-1519 (2006) [C1]
DOI 10.1016/j.socscimed.2005.07.037
Citations Scopus - 22Web of Science - 14
Co-authors Mddah01
2006 McGettigan PG, Han PY, Henry DA, 'Cyclooxygenase-2 inhibitors and coronary occlusion - Exploring dose-response relationships', British Journal of Clinical Pharmacology, 62 358-365 (2006) [C1]
DOI 10.1111/j.1365-2125.2006.02660.x
Co-authors Mddah01
2006 Carless PA, Henry DA, 'Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery', British Journal of Surgery, 93 810-819 (2006) [C1]
DOI 10.1002/bjs.5432
Citations Scopus - 59Web of Science - 50
Co-authors Mddah01
2006 McNeill PM, Kerridge IH, Henry DA, Stokes BJ, Hill SR, Newby DA, et al., 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia', Internal Medicine Journal, 36 571-578 (2006) [C1]
DOI 10.1111/j.1445-5994.2006.01151.x
Citations Scopus - 19Web of Science - 17
Co-authors Jane Maguire, Barrie Stokes, Mddah01, David Newby
2006 Doran E, Henry DA, 'Pharmaceutical benefits scheme policy: confused and tough on patients (Editorial)', Internal Medicine Journal, 36 211-213 (2006) [C3]
Citations Scopus - 5Web of Science - 4
Co-authors Mddah01
2006 McNeill PM, Kerridge I, Henry DA, 'Reply', Internal Medicine Journal, 36 796-797 (2006) [C3]
Co-authors Mddah01
2006 Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA, 'Cell Salvage for Minimising Perioperative Allogeneic Blood Transfusion', Cochrane Database of Systematic Reviews, 4 (2006) [C1]
DOI 10.1002/14651858.CD001888
Citations Scopus - 29Web of Science - 5
Co-authors Mddah01
2006 Harris A, Hill SR, Henry DA, 'Cost-effectiveness and resource allocation - Reply', JAMA - Journal of the American Medical Association, 295 2723-2724 (2006) [C3]
Citations Scopus - 1
Co-authors Mddah01
2006 Moynihan R, Henry DA, 'The fight against disease mongering: Generating knowledge for action', Plos Medicine, 3 e191 (2006) [C2]
Citations Scopus - 111
Co-authors Mddah01
2005 Henry DA, Doran E, Kerridge I, Hill SR, McNeill PM, Day R, 'Ties that bind - Multiple relationships between clinical researchers and the pharmaceutical industry', Archives of Internal Medicine, 165 2493-2496 (2005) [C1]
DOI 10.1001/archinte.165.21.2493
Citations Scopus - 14Web of Science - 11
Co-authors Mddah01
2005 Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, et al., 'Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience', Medical Journal of Australia, 182 557-560 (2005) [C1]
Citations Scopus - 30Web of Science - 27
Co-authors Barrie Stokes, Jane Maguire, David Newby, Mddah01
2005 Smith DE, Wilson AJ, Henry DA, 'Monitoring the quality of medical news reporting: Early experience with media doctor', Medical Journal of Australia, 183 190-193 (2005) [C1]
Citations Scopus - 34Web of Science - 32
Co-authors Mddah01, Amanda Wilson
2005 Moxey AJ, O'Connell DL, Treloar CJ, Han PYS, Henry DA, 'Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public', Transfusion Medicine, 15 19-32 (2005) [C1]
DOI 10.1111/j.1365-3148.2005.00544.x
Citations Scopus - 9Web of Science - 10
Co-authors Mddah01
2005 Carless PA, Henry DA, 'Systematic review of autologous transfusion techniques (Reply)', Transfusion Medicine, 15 256-256 (2005) [C3]
Co-authors Mddah01
2005 Kerridge I, Maguire JM, Newby DA, McNeill PM, Henry DA, Hill SR, et al., 'Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations', Internal Medicine Journal, 35 206-210 (2005) [C1]
DOI 10.1111/j.1444-0903.2004.00799.x
Citations Scopus - 11Web of Science - 6
Co-authors Jane Maguire, Barrie Stokes, Mddah01, David Newby
2005 Day RO, Birkett DJ, Miners J, Shenfield GM, Henry DA, Seale JP, 'Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology (Conference report)', Medical Journal of Australia, 182 322-323 (2005) [C1]
Citations Web of Science - 5
Co-authors Mddah01
2005 Carless PA, Moxey AJ, Stokes BJ, Henry DA, 'Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials', BMC Cardiovascular Disorders, 5 (2005) [C1]
DOI 10.1186/1471-2261-5-19
Citations Scopus - 47
Co-authors Barrie Stokes, Mddah01
2005 McGettigan PG, Henry DA, 'Medical research and the news media', New England Journal of Medicine, 352 838-840 (2005) [C1]
DOI 10.1056/NEJM200502243520821
Co-authors Mddah01
2005 Henry DA, Hill SR, Harris A, 'Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme (Commentary)', Journal of the American Medical Association, 294 2630-2632 (2005) [C1]
DOI 10.1001/jama.294.20.2630
Citations Scopus - 62Web of Science - 49
Co-authors Mddah01
2005 Schwitzer G, Mudur G, Henry DA, Wilson AJ, Goozner M, Simbra M, et al., 'What are the roles and responsibilities of the media in disseminating health information?', Plos Medicine, 2 576-582 (2005) [C1]
DOI 10.1371/journal.pmed.0020215
Citations Scopus - 40Web of Science - 32
Co-authors Mddah01, Amanda Wilson
2005 Faunce T, Doran E, Henry DA, Drahos P, Searles A, Pekarsky B, Neville W, 'Assessing the impact of the Australian-United States free trade agreement on Australian and global medicines policy', Globalization and Health, 1 (2005) [C1]
DOI 10.1186/1744-8603-1-15
Citations Scopus - 19Web of Science - 9
Co-authors Mddah01
2004 Mansfield P, Henry DA, Tonkin A, 'Single-Enantiomer Drugs. Elegant Science, Disappointing Effects', Clinical Pharmacokinetics, 43 287-290 (2004) [C1]
DOI 10.2165/00003088-200443050-00002
Co-authors Mddah01
2004 Drahos P, Lokuge B, Faunce T, Goddard M, Henry DA, 'Pharmaceuticals, Intellectual Property and Free Trade: The Case of the US-Australia Free Trade Agreement', Prometheus, 22 243-257 (2004) [C1]
DOI 10.1080/0810902042000255705
Co-authors Mddah01
2004 Carless PA, Moxey AJ, O'Connell DL, Henry DA, 'Autologous transfusion techniques: systematic review of their efficacy', Transfusion Medicine, 14 123-144 (2004) [C1]
DOI 10.1111/j.0958-7578.2004.0489.x
Citations Scopus - 79Web of Science - 64
Co-authors Mddah01
2004 Drahos P, Henry DA, 'The free trade agreement between Australia and the United States, Undermines Australian public health and protects US interests in pharmaceuticals', BMJ, 328 1271-1272 (2004) [C3]
Co-authors Mddah01
2004 Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al., 'Grading quality of evidence and strength of recommendations', BMJ, 328 1-8 (2004) [C1]
DOI 10.1136/bmj.328.7454.1490
Co-authors Mddah01
2004 Mansfield PR, Henry DA, 'Misleading drug promotion- no sign of improvements', Pharmacoepidemiology and drug safety, 13 797-799 (2004) [C3]
Co-authors Mddah01
2004 Doran E, Robertson J, Rolfe IE, Henry DA, 'Patient co-payments and use of prescription medicines', Australian and New Zealand Journal of Public Health, 28 62-67 (2004) [C1]
DOI 10.1111/j.1467-842X.2004.tb00634.x
Citations Scopus - 25Web of Science - 23
Co-authors Mddah01
2004 Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry DA, Hill SR, et al., 'Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group', BMC Health Services Research, 4 1-7 (2004) [C1]
DOI 10.1186/1472-6963-4-38
Citations Scopus - 282Web of Science - 264
Co-authors Mddah01
2003 Henry DA, McGettigan PG, 'Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs', International Journal of Clinical Practice, 135 43-49 (2003) [C1]
Co-authors Mddah01
2003 Henry DA, Lang DL, 'Published pharmacoeconomic analyses: science or marketing?', Internal Medicine Journal, 33 404-404 (2003) [C3]
Co-authors Danielle Lang, Mddah01
2003 Carless PA, Rubens FD, Anthony DM, O'Connell DL, Henry DA, 'Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, - CD004172 (2003) [C1]
DOI 10.1002/14651858.cd004172
Citations Scopus - 2
Co-authors Mddah01
2003 Carless PA, Henry DA, Anthony DM, 'Fibrin sealant use for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 4 (2003) [C3]
Citations Scopus - 7
Co-authors Mddah01
2003 Newby DA, Fryer JL, Henry DA, 'Effect of computerised prescribing on use of antibiotics', Medical Journal of Australia, 178 210-213 (2003) [C1]
Citations Scopus - 12Web of Science - 9
Co-authors Mddah01, David Newby
2003 Doran E, Henry DA, 'The PBS community awareness campaign: how helpful is blaming patients', Medical Journal of Australia, 179 544-545 (2003) [C1]
Citations Scopus - 10Web of Science - 8
Co-authors Mddah01
2003 Henry DA, Salkeld G, 'Bridges to Iran', The Lancet, 361 438 (2003) [C3]
Co-authors Mddah01
2003 Henry DA, Lexchin J, 'Patent law', The Lancet, 361 1059 (2003) [C3]
DOI 10.1016/s0140-6736(03)12810-3
Co-authors Mddah01
2003 Henry DA, Lexchin J, 'Pfizer Diflucan Partnership Program: Authors' reply', The Lancet, 361 72 (2003) [C3]
DOI 10.1016/s0140-6736(03)12125-3
Co-authors Mddah01
2003 Robertson J, Treloar CJ, Sprogis A, Henry DA, 'The influence of specialists on prescribing GPs: A qualitative study', Australian Family Physician, 32 573-576 (2003) [C1]
Citations Scopus - 15
Co-authors Mddah01
2003 Moxey AJ, O'Connell DL, McGettigan PG, Henry DA, 'Describing treatment effects to patients: How they are expressed makes a difference', Journal of General Internal Medicine, 18 948-959 (2003) [C1]
DOI 10.1046/j.1525-1497.2003.20928.x
Citations Scopus - 69Web of Science - 58
Co-authors Mddah01
2003 Lelorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA, 'Bringing epidemology into drug utilisation research', Pharmacoepidemiology & Drug Safety: an International Journal, 12 153-156 (2003) [C1]
DOI 10.1002/pds.817
Citations Scopus - 1Web of Science - 1
Co-authors Mddah01
2002 Carless PA, Anthony DM, Henry DA, 'Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion', British Journal of Surgery, 89 695-703 (2002) [C1]
Citations Scopus - 63Web of Science - 47
Co-authors Mddah01
2002 Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators', Medical Journal of Australia, 176 419-424 (2002) [C1]
Citations Scopus - 14Web of Science - 13
Co-authors Mddah01, Anthony Smith
2002 Newby DA, Henry DA, 'Drug advertising: truths, half-truths and few statistics', Medical Journal of Australia, 177(6) 285-286 (2002) [C3]
Citations Scopus - 5Web of Science - 2
Co-authors Mddah01, David Newby
2002 Lopert R, Lang DL, Hill SR, Henry DA, 'Differential pricing of drugs: a role for cost-effectiveness analysis?', The Lancet, 359 2105-2107 (2002) [C1]
Citations Scopus - 17Web of Science - 15
Co-authors Danielle Lang, Mddah01
2002 Henry DA, Lexchin J, 'The Pharmaceutical Industry as a medicines provider', The Lancet, 360 1590-1595 (2002) [C1]
Co-authors Mddah01
2002 Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, et al., 'V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women', Endocrine Reviews, 23(4) 529-539 (2002) [C1]
Co-authors Mddah01
2002 Lopert R, Henry DA, 'The Pharmaceutical Benefits Scheme: economic evaluation works ... but is not a panacea', Australian Prescriber, 25(6) 126-127 (2002) [C1]
Co-authors Mddah01
2002 Carson J, Hill SR, Carless PA, Hebert P, Henry DA, 'Transfusion Triggers: a systematic review of the literature', Transfusion Medicine Reviews, 16(3) 187-199 (2002) [C1]
DOI 10.1053/tmrv.2002.33461
Co-authors Mddah01
2002 Moynihan R, Heath I, Henry DA, 'Selling sickness: The pharmaceutical industry and disease mongering', British Medical Journal, 324 886-891 (2002) [C1]
Citations Scopus - 440Web of Science - 319
Co-authors Mddah01
2002 Henry DA, Carless PA, Moxey A, O'Connell DL, Forgie M, Wells P, Fergusson D, 'Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
Citations Scopus - 9
Co-authors Mddah01
2002 Hill SR, Carless PA, Henry DA, Carson J, Hebert P, McClelland D, Henderson K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
Citations Scopus - 54
Co-authors Mddah01
2001 Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA, 'The impact of specialists on prescribing by general practitioners', Medical Journal of Australia, 175 407-411 (2001) [C1]
Citations Scopus - 23Web of Science - 18
Co-authors Mddah01
2001 Henry DA, Birkett D, 'Changes to the Pharmaceutical Benefits Advisory Committee', Medical Journal of Australia, 174(5) 209-210 (2001) [C3]
Citations Scopus - 9Web of Science - 8
Co-authors Mddah01
2001 Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Personal Formularies. An index of prescribing quality?', European Journal of Clinical Pharmacology, 57 333-341 (2001) [C1]
Citations Scopus - 16Web of Science - 16
Co-authors Mddah01, Anthony Smith
2001 Newby DA, Hill SR, Barker B, Drew A, Henry DA, 'Drug information for consumers: should it be disease or medication specific? Results of a community survey', Australian and New Zealand Journal of Public Health, 25(6) 564-570 (2001) [C1]
Citations Scopus - 15Web of Science - 12
Co-authors Mddah01, David Newby
2001 Treloar C, Hewitson P, Henderson KM, Harris G, Henry DA, McGrath K, 'Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders', Internal Medicine Journal, 31 230-236 (2001) [C1]
Citations Web of Science - 4
Co-authors Mddah01
2000 Henry DA, Henderson KM, Fryer JL, Treloar C, McGrath K, Deveridge S, 'Use of interventions to minimise perioperative allogeneic blood transfusion in Australia', Medical Journal of Australia, 172 365-369 (2000) [C1]
Co-authors Mddah01
2000 McManus M, Henry DA, Birkett B, 'Recent changes in the profile of prescription NSAID use in Australia', Medical Journal of Australia, 172 188 (2000) [C3]
Citations Web of Science - 4
Co-authors Mddah01
2000 Moynihan M, Bero B, Ross-Degnan R, Henry DA, Lee L, Soumerai H, 'Coverage by the news media of the benefits and risks of medications', The New England Journal of Medicine, 342(22) 1645-1650 (2000) [C1]
Citations Scopus - 232Web of Science - 189
Co-authors Mddah01
2000 Hill SR, Mitchell A, Henry DA, 'Problems with the Interpretation of Pharmacoeconomic Analyses', JAMA, 283(16) 2116-2121 (2000) [C1]
Co-authors Mddah01
2000 Lowe J, Candish P, Henry DA, Wlodarcyk J, Fletcher P, 'Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure', International Journal for Quality in Health Care, 12(4) 339-345 (2000) [C1]
Citations Web of Science - 6
Co-authors Mddah01
2000 Henry DA, McGettigan PG, 'Rofecoxib caused few endoscopic gastroduodenal ulcers than ibuprofen in osteoarthritis ( Laine L et al/Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers (Simon LS et al) - Commentary', Evidence-Based Medicine (EBM), 5 74 (2000) [C3]
Co-authors Mddah01
2000 Page J, Henry DA, 'Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients', Archives of Internal Medicine, 160(6) 777-784 (2000) [C1]
Co-authors Mddah01
1999 Henry DA, Hill SR, 'Assessing new health technologies: lessons to be learned from drugs', Medical Journal of Australia, 171 554-556 (1999) [C1]
Citations Web of Science - 3
Co-authors Mddah01
1999 Henry DA, Robertson J, 'Pharmacists' outreach visits and doctors' prescribing', Medical Journal of Australia, 170 460-461 (1999) [C2]
Co-authors Mddah01
1999 Henry DA, Lopert R, 'Pharmacoeconomics and Policy Decisions: The Australian Health Care System', Clinical Therapeutics, 21(5) 909-915 (1999) [C1]
Co-authors Mddah01
1999 Ferguson D, Blair A, Henry DA, Hisashige A, Huet C, Koopman-Van Gemert A, et al., 'Technologies to minimize blood transfusion in cardiac and orthopedic surgery', International Journal of Technology Assessment in Health Care, 15 (4) 717-728 (1999) [C1]
Co-authors Mddah01
1999 Robertson J, Henry DA, Dobbins T, Sprogis A, Terry R, Ireland M, 'Prescribing patterns in general practice', Australian Family Physician, 28 (11) 1186-1190 (1999) [C1]
Co-authors Mddah01
1999 McGettigan PG, Sly K, O'Connell DL, Hill SR, Henry DA, 'The Effects of Information Framing on the Practices of Physicians', Journal of General Internal Medicine, 14 633-642 (1999) [C1]
Citations Scopus - 77Web of Science - 61
Co-authors Mddah01
1999 Nikolajevic-Sarunac J, Henry DA, O'Connell DL, Robertson J, 'Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy', Journal of General Internal Medicine, 14 591-598 (1999) [C1]
Citations Scopus - 19Web of Science - 15
Co-authors Mddah01
1999 O'Connell DL, Henry DA, Tomlins R, 'Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia', British Medical Journal, 318 507-511 (1999) [C1]
Citations Scopus - 100Web of Science - 85
Co-authors Mddah01
1999 Henry DA, Hill SR, 'Meta-analysis - Its Role in Assessing Drug Safety', Pharmacoepidemiology and Drug Safety, 8(3) 167-168 (1999) [C2]
Co-authors Mddah01
1999 Whitworth J, Lang DL, Henry DA, 'Cost-effectiveness Analysis in the Treatment of Hypertension: A Medical View', Clinical and Experimental Hypertension, 21(5-6) 999-1008 (1999) [C1]
Co-authors Danielle Lang, Mddah01
1998 Henry DA, 'Commentary', ACP Journal Club, July/August 1998 10 (1998) [C3]
Co-authors Mddah01
1998 Kerridge I, Lowe M, Henry DA, 'Ethics and Evidence-Based Medicine', British Medical Journal, 316 1151-1153 (1998) [C1]
Co-authors Mddah01
1998 O'Connell DL, Robertson J, Henry DA, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects', Climacteric, 1 (2) 112-123 (1998) [C1]
Citations Scopus - 46
Co-authors Mddah01
1998 Henry DA, Robertson J, O'Connell DL, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in post-menopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995', Climacteric, 1 (2) 92-111 (1998) [C1]
Citations Scopus - 17
Co-authors Mddah01
1998 Lowe J, Candish P, Henry DA, Wiodarcul J, Heller E, Fletcher P, 'Management and outcomes of congestive heart failure: a prospective study of hospitalised patients', Medical Journal of Australia, 168 115-118 (1998) [C1]
Co-authors Mddah01
1998 Porteous J, Robertson J, Henry DA, 'Pharmaceutical security: a new research agenda?', The Medical Journal of Australia, 169 (5) 262-263 (1998) [C2]
Co-authors Mddah01
Show 113 more journal articles

Review (3 outputs)

Year Citation Altmetrics Link
2004 Hill SR, Carless PA, Henry DA, Carlson JL, Herbert PC, McClelland DBL, Henderson KM, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews (2004) [D1]
Citations Scopus - 103
Co-authors Mddah01
2003 Aaserud M, Dahlgren AT, Sturm H, Kosters JP, Hill SR, Furberg CD, et al., 'Pharmaceutical policies: effects on rational drug use', Cochrane Database of Systematic Reviews (2003) [D1]
Co-authors Mddah01
2003 Henry DA, Moxey AJ, Carless PA, O'Connell DL, McClelland B, Henderson KM, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews (2003) [D2]
Citations Scopus - 180Web of Science - 3
Co-authors Mddah01

Conference (4 outputs)

Year Citation Altmetrics Link
2004 Moxey AJ, O'Connell DL, Deveridge SF, Treloar CJ, Henry DA, 'Involving older patients in decision making: a decision aid describing blood transfusion options for planned surgery', Abstracts and Proceedings of ERA 2004, Brisbane (2004) [E1]
Co-authors Mddah01
2001 Carless PA, Hill SR, Henry DA, 'How low can we go? Lower thresholds for red cell transfusion', Destination downunder turning your thinking upside down : proceedings of the 4th International Conference on the Scientific Basis of Health Services, Sydney, Australia (2001) [E3]
Co-authors Mddah01
1998 McGettigan PG, Henry DA, Page J, 'Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal tract and kidney: Relationship to cyclooxygenase-2 selectivity', Clinical significance and potential of selective COX-2 inhibitors, Phuket, Thailand (1998) [E2]
Co-authors Mddah01
1998 Henry DA, Drew A, Beuzeville S, 'Adverse drug reactions in the gastrointestinal system attributed to ibuprofen', Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs, South San Francisco Conference Centre (1998) [E1]
Co-authors Mddah01
Show 1 more conference
Edit

Grants and Funding

Summary

Number of grants 52
Total funding $12,678,379

Click on a grant title below to expand the full details for that specific grant.


20081 grants / $150,000

Pharmaceutical Promotion: Productive or Problematic?$150,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Doctor Evan Doran, Conjoint Professor David Henry, Mr Ray Moynihan
Scheme Discovery Projects
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0187476
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20075 grants / $1,668,562

NIPH Capacity Building Infrastructure grant$1,472,398

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Conjoint Professor David Henry, Professor Julie Byles, Professor John Wiggers, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Durrheim
Scheme NIPH Capacity Building Infrastructure grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187399
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Moral Hazard and the Pharmaceutical Benefits Scheme$166,000

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Doctor Evan Doran, Conjoint Professor David Henry, Associate Professor G Salkeld, Doctor Jane Robertson
Scheme Discovery Projects
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0186334
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Improving the quality of health news reports in the Australian media$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Conjoint Professor David Henry, Doctor Amanda Wilson
Scheme Project Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187253
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

The quality of health news reports about complementary and alternative medicine in Australian lay media$8,702

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor Alison Jones, Associate Professor Billie Bonevski, Conjoint Professor David Henry, Doctor Amanda Wilson
Scheme Pilot Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187836
Type Of Funding Internal
Category INTE
UON Y

Sri Lanka Medical Association 120th Annual Scientific Sessions, Colombo, 21/3/2007 - 24/3/2007$1,462

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187382
Type Of Funding Internal
Category INTE
UON Y

20065 grants / $696,860

PRC - Priority Research Centre for Gender health & Ageing$543,772

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Julie Byles, Professor Sandra Capra, Associate Professor Pauline Chiarelli, Conjoint Professor David Henry, Professor Tina Koch, Ms Chris Landorf, Conjoint Professor Chris Levi, Associate Professor Deb Loxton, Associate Professor Liz Milward, Conjoint Associate Professor Lynne Parkinson, Professor Dimity Pond, Conjoint Professor David Sibbritt, Associate Professor Anne Young
Scheme Priority Research Centre
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186949
Type Of Funding Internal
Category INTE
UON Y

Harmful or protective: low-dose selective cox-2 inhibitors and coronary or cerebrovascular occlusion$111,000

Funding body: National Heart Foundation of Australia

Funding body National Heart Foundation of Australia
Project Team Conjoint Professor David Henry, Dr Patricia McGettigan
Scheme Grant-In-Aid
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0185371
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Harmful or protective? Low dose COX-2 inhibitors and coronary or cerebrovascular occlusion$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry, Dr Patricia McGettigan, Conjoint Professor Chris Levi
Scheme Near Miss Grant
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186057
Type Of Funding Internal
Category INTE
UON Y

Establishing a linked record system to optimise the use of longitudinal health-related datasets: illustrated by two studies of medication use$19,688

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Associate Professor Anne Young, Conjoint Associate Professor Lynne Parkinson, Professor Julie Byles, Conjoint Professor David Henry
Scheme Pilot Grant
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186687
Type Of Funding Internal
Category INTE
UON Y

XIV Cochrane Colloquium, Dublin 2006, 23-27 October 2006$2,400

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0186970
Type Of Funding Internal
Category INTE
UON Y

20053 grants / $3,357,466

External Evaluation of PBAC Submissions RFP 163/0304$3,221,378

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Doctor Jane Robertson, Conjoint Professor David Henry
Scheme Consultancy/Tender
Role Investigator
Funding Start 2005
Funding Finish 2005
GNo G0184477
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

The impact of International Trade Agreements on the regulation and provision of medicines in Australia$116,088

Funding body: ARC (Australian Research Council)

Funding body ARC (Australian Research Council)
Project Team Conjoint Professor David Henry
Scheme Discovery Projects
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185098
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Establishment of a Clinical Research Database for Hunter Stroke Service$20,000

Funding body: Hunter New England Area Health Service

Funding body Hunter New England Area Health Service
Project Team Conjoint Professor David Henry
Scheme Hunter Stroke Service
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185608
Type Of Funding Not Known
Category UNKN
UON Y

20042 grants / $29,586

Novel genetic and environmental risk factors in atherothrombosis: The role of variation in Cox-2, tpA and PAI-1 activity$28,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Conjoint Professor Chris Levi, Conjoint Professor David Henry, Dr Patricia McGettigan, Professor John Attia, Professor Mark Parsons, Dr Michael Seldon, Professor Rodney Scott
Scheme Research Grant
Role Investigator
Funding Start 2004
Funding Finish 2004
GNo G0183749
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

The Cochrane Collaboration Colloquium, 2-6 October 2004, Canada$1,586

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0184822
Type Of Funding Internal
Category INTE
UON Y

20031 grants / $161,000

COX-2 inhibitors and the development of unstable angina and myocardial infarction$161,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
Scheme Project Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0181781
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20021 grants / $271,500

COX-2 inhibitors as a cause of heart and renal failure$271,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe, Conjoint Professor Ian Whyte
Scheme Project Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0180892
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20013 grants / $187,144

An investigation of the relationship between the pharmaceutical industry, medical profession and medical practitioners.$185,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Dr Ian Kerridge, Conjoint Professor David Henry, Associate Professor Suzanne Hill, Assoc. Prof P McNeill
Scheme Project Grant
Role Investigator
Funding Start 2001
Funding Finish 2001
GNo G0179679
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Cochrane Colloquium (annual meeting) France 9-13 October, 2001$2,143

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0181555
Type Of Funding Internal
Category INTE
UON Y

To Provide Independent Reviews of Draft Health Advisory Reports.$1

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Associate Professor Rosemary Aldrich, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Henry, Professor Julie Byles
Scheme Consultancy/Tender
Role Investigator
Funding Start 2001
Funding Finish 2001
GNo G0180846
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20002 grants / $296,150

Alternatives to homologous blood transfusion - development of evidence-based decision aids.$213,697

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Sandra Deveridge
Scheme Project Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0178462
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Review of the risks associated with the use of NSAID's.$82,453

Funding body: Whitehall-Robbins Health Care Division

Funding body Whitehall-Robbins Health Care Division
Project Team Conjoint Professor David Henry
Scheme American Home Products Corporation
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0180168
Type Of Funding International - Non Competitive
Category 3IFB
UON Y

19991 grants / $75,000

Pharmaceutical Affordability and the Quality Use of Medicines.$75,000

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Doctor Evan Doran, Conjoint Professor David Henry
Scheme Pharmaceutical Education Program (PEP)
Role Investigator
Funding Start 1999
Funding Finish 1999
GNo G0178749
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

19988 grants / $4,303,860

External Evaluation of PBAC Submissions$3,761,049

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Associate Professor Suzanne Hill, Conjoint Professor David Henry
Scheme Consultancy/Tender
Role Investigator
Funding Start 1998
Funding Finish 1998
GNo G0178712
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Integrated Care Program.$150,000

Funding body: Merck Sharp & Dohme Aust Pty Ltd

Funding body Merck Sharp & Dohme Aust Pty Ltd
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
Scheme Research Grant
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0178621
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

The effect of different forms of information framing on helath care practices$122,786

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
Scheme Project Grant
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0177173
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Developing Assessment Guidelines for the Medicare Services Advisory Committee$121,885

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Medicare Services Advisory Committee
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0178236
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Development of a strategy to measure consumer participation in decisions about health service delivery$56,063

Funding body: NSW Health

Funding body NSW Health
Project Team Professor Jill Cockburn, Conjoint Professor David Henry, Associate Professor David Newby
Scheme Ministerial Advisory Committee - Quality in Health Care
Role Investigator
Funding Start 1998
Funding Finish 1998
GNo G0177842
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Improving treatment decisions: accurate generalisation of clinical trial results$49,626

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
Scheme Project Grant
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0177174
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A Review of the Scientific Literature Concerning the Alternatives to Homologous Blood Donations$39,121

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Health Goals & Targets
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0177846
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Attendance and participation in the International Society of Technology Assessement in Health Care conference (ISTAHC) - Ottowa$3,330

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Medicare Services Advisory Committee
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0177970
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

19977 grants / $380,829

Review of the Consumer Drug Information Services$106,518

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Associate Professor David Newby, Conjoint Professor David Henry, Associate Professor Suzanne Hill
Scheme Pharmaceutical Education Program (PEP)
Role Investigator
Funding Start 1997
Funding Finish 1997
GNo G0177050
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Newcastle Prescriber Database$78,250

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Jane Robertson
Scheme General Practice Evaluation Program (GPEP) (Defunct)
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0176055
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

The impact of specialists on prescribing by Australian general practitioners.$77,357

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry, Doctor Arn Sprogis, Doctor Jane Robertson
Scheme General Practice Evaluation Program (GPEP) (Defunct)
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0177040
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Value of non-randomised studies for assessing the effectiveness of medical interventions$67,698

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell
Scheme Project Grant
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0176234
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Public Participation in Resource Allocation in Health$43,600

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Associate Professor David Newby, Conjoint Professor David Henry, Doctor Gloria Higginbottom, Professor Jill Cockburn, Associate Professor Suzanne Hill
Scheme Pharmaceutical Education Program (PEP)
Role Investigator
Funding Start 1997
Funding Finish 1997
GNo G0177552
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Evaluation of Hospital in the Home - design of protocol$4,906

Funding body: Macquarie Health Corporation

Funding body Macquarie Health Corporation
Project Team Conjoint Professor David Henry
Scheme Research Grant
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0177004
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

International Congress in Pharmacoepidemiology, Orlando, Florida, 24-27 August 1997$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0179481
Type Of Funding Internal
Category INTE
UON Y

19963 grants / $97,608

Development, Testing and Refining of Indicators of Quality of Prescribing by General Practitioners$66,108

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Doctor Jane Robertson, Conjoint Professor David Henry
Scheme PHRDC Research Fellowship (Defunct)
Role Investigator
Funding Start 1996
Funding Finish 1996
GNo G0177702
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Phamaceuticals Project Stage 2$20,000

Funding body: Consumers` Health Forum of Australia Inc.

Funding body Consumers` Health Forum of Australia Inc.
Project Team Conjoint Professor David Henry, Ms B Pekarsky
Scheme Research Grant
Role Lead
Funding Start 1996
Funding Finish 1996
GNo G0176517
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

An examination of the risk of sudden death during therapeutic use of thioridazine and desipramine by systematic review of randomised controlled trials$11,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Dr Nicholas Buckley, Conjoint Professor David Henry
Scheme Project Grant
Role Investigator
Funding Start 1996
Funding Finish 1996
GNo G0175828
Type Of Funding Internal
Category INTE
UON Y

19954 grants / $734,067

The External Evaluation of PBAC Submissions$555,741

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Pharmaceutical Education Program (PEP)
Role Lead
Funding Start 1995
Funding Finish 1995
GNo G0175545
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

Assessing and increasing the generalisabiity of RCTs$107,448

Funding body: UK National Health Service

Funding body UK National Health Service
Project Team Conjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Professor D Sackett, Mr P Glasziou
Scheme Research & Development Program Grants
Role Lead
Funding Start 1995
Funding Finish 1995
GNo G0175419
Type Of Funding International - Non Competitive
Category 3IFB
UON Y

Conducting Analysis on Prescribing for Major Groups of Prescription Pharmacueticals which might explain the Variability in Prescribing Rates and Total ...$48,632

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Research & Development Grant (RADGAC)
Role Lead
Funding Start 1995
Funding Finish 1995
GNo G0175210
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

General Practitioners Beliefs Regarding Benefits and Risks of Hormone Replacement Therapy$22,246

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Conjoint Professor David Henry
Scheme Research & Development Grant (RADGAC)
Role Lead
Funding Start 1995
Funding Finish 1995
GNo G0175208
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

19942 grants / $122,500

94GRANT. Speciality grant for Pharmacoepidemiology.$120,000

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Emeritus Professor Anthony Smith, Conjoint Professor David Henry
Scheme Pharmaceutical Education Program (PEP)
Role Investigator
Funding Start 1994
Funding Finish 1994
GNo G0174635
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

10 International Conference on Pharmacoepidemiology - Stockholm - 28-31 August 1994$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 1994
Funding Finish 1994
GNo G0175071
Type Of Funding Internal
Category INTE
UON Y

19932 grants / $10,560

A Meta-Analysis of Falls in Old Age.$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Paul Finucane, Conjoint Professor David Henry
Scheme New Staff Grant
Role Investigator
Funding Start 1993
Funding Finish 1993
GNo G0172985
Type Of Funding Internal
Category INTE
UON Y

'9th International Conference on Pharmacoepidemiology', JW Marriott Hotel, Washington DC, USA, 29 August - 1 September 1993$560

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 1993
Funding Finish 1993
GNo G0174397
Type Of Funding Internal
Category INTE
UON Y

19922 grants / $135,687

Acute Renal Impairment And Cardiac Failure With Nsaids. A Community Study.$133,341

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor David Henry
Scheme Project Grant
Role Lead
Funding Start 1992
Funding Finish 1992
GNo G0174270
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

12th International Meeting of the International Society of Technology Assessment in Health Care, San Francisco, 23-26 June 1996$2,346

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor David Henry
Scheme Travel Grant
Role Lead
Funding Start 1992
Funding Finish 1992
GNo G0176432
Type Of Funding Internal
Category INTE
UON Y
Edit

Research Supervision

Number of supervisions

Completed7
Current0

Past Supervision

Year Level of Study Research Title / Program / Supervisor Type
2010 PhD A Preliminary Analysis of the Pharmaceutical Provisions in the Australia-United States Free Trade Agreement on Prescription Medicines in Australia
Public Health, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2010 PhD Assessing the Quality of Health News Stories in the Australian Media Using the Media Doctor Website
Public Health, Faculty of Education and Arts, The University of Newcastle
Co-Supervisor
2010 PhD Assessing the Quality of Health News Stories in the Australian Media Using the Media Doctor Website
Public Health, Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2007 PhD Evidence-Based Patient Decision Making: The Development of a Decision Aid on Blood Transfusion
Pharmacology, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2005 PhD Evaluation of Aspects of the South African National Drug Policy: Hypertension, a Case Study
Pharmacology, Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2003 PhD Pharmaceutical Affordability and Quality Use of Medicines
Pharmacology, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2002 PhD Public Participation in Health Care Decisions about Medicines
Pharmacology, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
Edit

Conjoint Professor David Henry

Position

Conjoint Professor
School of Medicine and Public Health
Faculty of Health and Medicine

Contact Details

Email david.henry@newcastle.edu.au
Phone +14163716947 (Canada)
Fax (02) 4960 2088

Office

Room NM2-535B
Edit